Back to Results
First PageMeta Content
Medical physics / Cancer treatments / Laser medicine / Photodynamic therapy / Aminolevulinic acid / Porfimer sodium / Levulan / Temoporfin / Talaporfin / Medicine / Photosensitizing agents / Light therapy


Document Date: 2004-06-15 16:31:04

Open Document

File Size: 192,48 KB

Share Result on Facebook

City

slough / Monte Carlo / /

Company

Axcan Pharma Inc. / Pharmacyclics / DUSA Pharmaceuticals Inc. / PhotoCure ASA / Elsevier B.V. / Hp / HPPH Phthalocyanine Axcan Pharma Inc. / Pharmaceuticals Pharmacylics Biolitec Pharma Ltd. / /

Country

United States / /

/

Event

FDA Phase / /

Facility

East Carolina University / PhotoCure ASA Novartis Pharmaceuticals Pharmacylics Biolitec Pharma Ltd. Light Science RPCI General Physics Institute / /

IndustryTerm

chemical reaction / Web site Porphyrin Porphyrin Porphyrin Porphyrin Texaphyrin Chlorin Chlorin Chlorin Dye / direct chemical structure / imaging / insurance decisions / chemical events / energy / carrier gives / chemical manipulation non-soluble photosensitizers / light energy / clinical utilities / degradation product / et al. chemical photosensitizer / miniature light device / high light energy / toxic chemical / light blocking devices / degradation products / modeling tools / bio-chemical profile / treatment of bladder cancer / chemical substitutions / chemical manipulation / quantitative planning systems / paramagnetic metal ion / reactive end products / /

MedicalCondition

neoplasms / superficial bladder cancers / breast cancer metastasis / good tumor / neck neoplasms / head neoplasms / bladder cancer / chest wall metastasis / skin photosensitization / illuminated tumors / i.e. hypotension / skin manifestations / head tumors / liver disease / breast cancer / brain tumors / actinic keratosis / tumor / tumors / peripheral arterial vascular disease / clinical PDT phototoxicity / stroke / malignant disease / cutaneous tumors / diseases / coronary artery disease / Kaposi sarcoma / Bladder tumors / embedded tumor / rash / disorders / pathologic myopia / late endobronchial disease / allergic reaction / chest pain / egg allergies / Locally recurrent tumors / peripheral paresthesias / choroidal neovascularization / oral cavity leukoplakia / rickets / neck tumors / blindness / cutaneous metastasis / necrosis / hypertension / disease / squamous cell cancers / pain / heart attack / rigors / choroidal melanoma / periprocedural myocardial infarction / tuberculosis / /

MedicalTreatment

light therapy / plastic surgery / surgery / radiation / radiation therapy / retreatment / chemotherapy / phototherapy / radiation treatment / Photodynamic therapy / catheter / /

Organization

East Carolina University / Greenville / Department of Medicine / Pulmonary and Critical Care Medicine / Department of Radiation Oncology / Systemic administration / Brody School of Medicine / FDA / Department of Surgical Oncology / Inc. PhotoCure ASA Novartis Pharmaceuticals Pharmacylics Biolitec Pharma Ltd. Light Science RPCI General Physics Institute / Department of Physics / Leo Jenkins Cancer Center / Outpatient administration / ALA PDT / /

Person

Ron R Allison / Rosa Cuenca / R. Allison et al. Purpurin / Leo Jenkins / Claudio H Sibata / Niels Finsen / Gordon H Downie / Xin-Hua Hu / /

Position

urological surgeon / Corresponding author / /

Product

Levulan / Photofrin / Hexvix / Visudyne / 1 drug / Antrin / Antrin® / Photofrin® / /

ProvinceOrState

Alabama / North Carolina / /

PublishedMedium

Critical Care Medicine / /

Technology

Radiation / apoptosis / chemotherapy / alpha / antibodies / MRI / /

URL

www.photocure.com / www.visudyne.com / www.dusapharma.com / www.gpi.ru / www.lightsciences.com / www.roswellpark.org / www.axcan.com / www.pharmacyclics.com / /

SocialTag